Diagnostic value of the anti-CD74 antibodies for axial spondyloarthritis: Results of a prospective study in patients with suspicious low back pain - 09/05/23
Doi : 10.1016/j.jbspin.2023.105533
Nelly Ziade a, b, ⁎ 
, Avin Maroof c, Antonella Abi Najm a, b, Torsten Witte d, Xenofon Baraliakos e
, Avin Maroof c, Antonella Abi Najm a, b, Torsten Witte d, Xenofon Baraliakos e a Saint-Joseph University, Beirut, Lebanon
b Hotel-Dieu de France Hospital, Beirut, Lebanon
c University of Kurdistan Hawler, Erbil, Iraq
d Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany
e Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany
⁎Corresponding author. Ville-Dieu center, Jean-Dominique Ayoub street, Achrafieh, Beirut, Lebanon.Ville-Dieu centerJean-Dominique Ayoub street, AchrafiehBeirutLebanon
Graphical abstract |
Highlights |
• | Diagnostic delay in axial spondyloarthritis may be reduced with reliable biomarkers. |
• | IgA antibodies against CD74 were significantly associated with axSpA. |
• | In the subgroup with negative HLA-B27, the positive LR was 2.7. |
• | IgA antibodies against CD74 were associated with symptom duration and sacroiliitis. |
Keywords : Spondyloarthritis, Diagnosis, Biomarker
Plan
© 2023
Société française de rhumatologie. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 3
Article 105533- mai 2023 Retour au numéro
Article précédent
- A case report of Polyarthritis as a new manifestation for Huntington's disease?
- Emmanuel Massy, Jean Roudier, Nathalie Balandraud
- Comment on: “The impact of diet on disease activity in spondyloarthritis: A systematic literature review” by Ortolan et al. Joint Bone Spine 2022;90:105476
- Dorra Ben Nessib, Fatma Majdoub, Hanene Ferjani Lassoued, Dhia Kaffel, Kaouther Matallah, Wafa Hamdi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?